论文部分内容阅读
目的探讨加替沙星和莫西沙星分别治疗下呼吸道感染的成本效果差异。方法 100例下呼吸道感染患者随机分为观察组和对照组,各50例。两组患者均给予常规处理,观察组患者同时给予加替沙星治疗。对照组患者同时给予莫西沙星治疗。分析两组治疗效果和成本。结果两组总有效率比较(观察组和对照组总有效率分别为94.0%和96.0%),差异无统计学意义(P>0.05)。观察组和对照组成本效果分别为446.8和2333.3。结论加替沙星和莫西沙星分别治疗下呼吸道感染均可获得较好临床治疗效果,但前者用药成本低,有助于减轻患者治疗负担。
Objective To investigate the cost-effectiveness of gatifloxacin and moxifloxacin in the treatment of lower respiratory tract infection respectively. Methods 100 cases of lower respiratory tract infection were randomly divided into observation group and control group, 50 cases each. Two groups of patients were given conventional treatment, the observation group were given gatifloxacin at the same time. Patients in the control group were treated with moxifloxacin. Analysis of two groups of treatment effects and costs. Results The total effective rate was compared between the two groups (the total effective rate was 94.0% in the observation group and 96.0% in the control group), the difference was not statistically significant (P> 0.05). The cost-effectiveness of observation group and control group were 446.8 and 2333.3 respectively. Conclusion Gatifloxacin and moxifloxacin can treat patients with lower respiratory tract infection, respectively. However, the former has a low cost and can reduce the burden of treatment.